FDX1 Human Pre-designed siRNA Set A
Based on 1 publication(s) in Google Scholar
FDX1 Human Pre-designed siRNA Set A contains three designed siRNAs for FDX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) FDX1 Human Pre-designed siRNA Set A
More
Biological Activity
FDX1 Human Pre-designed siRNA Set A contains three designed siRNAs for FDX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Components
FDX1 siRNA-1: 5 nmol (HPLC)
FDX1 siRNA-2: 5 nmol (HPLC)
FDX1 siRNA-3: 5 nmol (HPLC)
siRNA Negative Control: 5 nmol (HPLC)
FAM-labeled siRNA Negative Control: 5 nmol (HPLC)
GAPDH siRNA Positive Control: 5 nmol (HPLC)
FDX1 - ferredoxin 1 Gene (Human)
ADX; FDX; LOH11CR1D
Chemical Information
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Int Immunopharmacol
Hepatocyte cuproptosis promotes the progression of hepatic fibrosis: Emerging a potential therapeutic target. [Abstract]2026 Feb 1:170:116092. PMID: 41429062
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)